IL18 and neoplasm: A strong NK-cell activity and tumor specific cytotoxic T lymphocyte (CTL) response against Lewis lung carcinoma (LLC), with significant tumor regression, have also been observed on simultaneous administration of Apoptin and Interleukin-18 (Lian et al., 2007).